Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Cervical Intraepithelial Neoplasia; Precancerous Conditions; Uterine Cervical Neoplasms | Phase 1 | ClinicalTrials |
| Carcinoma; Carcinoma, Renal Cell; Kidney Neoplasms | Phase 2 | ClinicalTrials |
| Breast Neoplasms; Triple Negative Breast Neoplasms | Phase 2 | ClinicalTrials |
| Leukemia; Lymphoma; Myelodysplastic Syndromes; Neuroblastoma; Neuroectodermal Tumors; Neuroectodermal Tumors, Primitive; Osteosarcoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Rhabdomyosarcoma; Sarcoma, Ewing; Syndrome | Phase 1 | ClinicalTrials |
| Breast Neoplasms; Hypercalcemia; Neoplasms | Phase 3 | ClinicalTrials |
| Breast Neoplasms; Triple Negative Breast Neoplasms | Phase 2 | ClinicalTrials |
| Multiple Myeloma; Neoplasms, Plasma Cell | Phase 3 | ClinicalTrials |
| Breast Neoplasms | Phase 2 | ClinicalTrials |
| Bone Diseases, Metabolic; Osteoporosis | Phase 2 | ClinicalTrials |
| Breast Neoplasms; Neoplasm Metastasis; Prostatic Neoplasms | Phase 4 | ClinicalTrials |
| Breast Neoplasms | Phase 4 | ClinicalTrials |
CONTENTS